NCT07551115

Brief Summary

This prospective observational study aims to investigate the prevalence and clinical significance of two oral protozoa, Entamoeba gingivalis and Trichomonas tenax, among patients attending the Bolu Abant İzzet Baysal University Faculty of Dentistry, Department of Periodontology. While the oral microbiome typically maintains a delicate balance, disruptions in this ecosystem are thought to trigger periodontal diseases. Recent evidence suggests that these parasites may contribute to increased inflammation and tissue destruction, potentially playing a role in the etiology of gingivitis and periodontitis. The study will include 120 participants aged 18 and older who meet the inclusion criteria. Following the collection of demographic data and oral hygiene habits via a questionnaire, a single calibrated examiner will perform comprehensive clinical periodontal examinations. Measurements will include Plaque Index (PI), Gingival Index (GI), Bleeding on Probing (BOP), Probing Pocket Depth (PPD), Clinical Attachment Loss (CAL), and Gingival Recession (GR) based on the 2017 World Workshop Classification of Periodontal and Peri-Implant Diseases and Conditions. To detect the presence of parasites, unstimulated whole saliva samples and subgingival plaque samples from the deepest periodontal pockets will be collected from each participant. These samples will be analyzed immediately at the Parasitology Laboratory using light microscopy (10X and 40X magnification) to identify live trophozoites. By evaluating the relationship between parasite prevalence and periodontal status, this research aims to contribute to the limited literature on oral protozoa in Turkey and increase clinical awareness regarding their impact on oral health.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
3mo left

Started Dec 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress54%
Dec 2025Sep 2026

Study Start

First participant enrolled

December 22, 2025

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

April 20, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 24, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2026

Last Updated

April 24, 2026

Status Verified

April 1, 2026

Enrollment Period

6 months

First QC Date

April 20, 2026

Last Update Submit

April 20, 2026

Conditions

Keywords

gingivitisperiodontitisEntamoeba GingivalisTrichomonas Tenax

Outcome Measures

Primary Outcomes (1)

  • Prevalence of Entamoeba gingivalis and Trichomonas tenax

    The presence or absence of live trophozoites of Entamoeba gingivalis and Trichomonas tenax will be determined through light microscopic examination (10X and 40X magnification) of saliva and subgingival plaque samples. The outcome will be reported as the percentage (%) of participants testing positive for each parasite within the different periodontal health groups.

    Baseline (at the time of clinical examination and sample collection, typically within 1 hour).

Study Arms (3)

Periodontally Healthy

Systemically healthy individuals with no clinical signs of gingival inflammation (BOP \< 10%), no clinical attachment loss, and no probing depths \> 3 mm.

Diagnostic Test: Clinical Periodontal EvaluationProcedure: Microscopic Examination of Oral Protozoa

Gingivitis

Patients diagnosed with dental plaque-induced gingivitis characterized by bleeding on probing (BOP ≥ 10%) and no clinical attachment loss or radiographic bone loss, according to the 2017 World Workshop classification.

Diagnostic Test: Clinical Periodontal EvaluationProcedure: Microscopic Examination of Oral Protozoa

Periodontitis

Patients diagnosed with periodontitis (Stages I-IV) characterized by interdental clinical attachment loss, probing depths ≥ 4 mm, and radiographic evidence of alveolar bone loss.

Diagnostic Test: Clinical Periodontal EvaluationProcedure: Microscopic Examination of Oral Protozoa

Interventions

Comprehensive periodontal examination including Plaque Index, Gingival Index, Bleeding on Probing, Probing Pocket Depth, and Clinical Attachment Loss measurements using a Williams periodontal probe according to the 2017 World Workshop Classification.

GingivitisPeriodontally HealthyPeriodontitis

Collection of unstimulated saliva and subgingival plaque samples followed by immediate light microscopy examination (10X and 40X magnification) to detect the presence and frequency of Entamoeba gingivalis and Trichomonas tenax trophozoites.

GingivitisPeriodontally HealthyPeriodontitis

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients aged 18 and older who applied to the Bolu Abant İzzet Baysal University Faculty of Dentistry, Department of Periodontology, and met the inclusion criteria.

You may qualify if:

  • Participants aged 18 years or older.
  • Having at least 10 natural teeth.
  • Willingness to undergo periodontal examination and providing written informed consent.
  • Includes both periodontally healthy individuals and patients with gingivitis or periodontitis.

You may not qualify if:

  • Use of systemic antibiotics within the last 3 months.
  • Use of chlorhexidine or similar antiseptic mouthwashes within the last month.
  • Having received any periodontal treatment within the last 3 months.
  • Receiving immunosuppressive therapy or having a serious systemic immune deficiency.
  • Pregnancy or breastfeeding.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bolu Abant Izzet Baysal University, Faculty of Dentistry, Department of Periodontology

Bolu, Gölköy, 14030, Turkey (Türkiye)

RECRUITING

Biospecimen

Retention: SAMPLES WITHOUT DNA

Subgingival plaque and unstimulated saliva samples for microscopic examination.

MeSH Terms

Conditions

GingivitisPeriodontal DiseasesPeriodontitis

Condition Hierarchy (Ancestors)

InfectionsGingival DiseasesMouth DiseasesStomatognathic Diseases

Central Study Contacts

Bilge Meracı Yıldıran, Asst. Prof.

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

April 20, 2026

First Posted

April 24, 2026

Study Start

December 22, 2025

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

September 1, 2026

Last Updated

April 24, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations